You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海南、廣東再有集中採購藥品降價 最高降幅98%
據《央視》報道,自昨日(10日)起,海南省將正式執行第五批國家組織藥品集中採購、八省二區省際聯盟(第二批)集中採購、重慶聯盟常用藥集中採購和重慶聯盟短缺藥集中採購等四個批次中選結果,涉及125種藥品降價,平均降幅分別爲67.78%、78.09%、46.65%、13.01%,最高降幅達98%,預計首年度將節約藥品費用2.21億元人民幣。 此外,廣東省醫療保障局發佈第五批國家組織藥品集中帶量採購中選結果在廣東落地執行。自上週六(9日) 零時起,患者可在全省公立醫療機構按中選價格購買到平均降幅55%的61個藥品,最高降幅達到98%。(ta/w) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account